Dr Travis Rieder discusses his own experiences with opioids and the ethical challenges of “legacy patients,” and Dr Stephanie Zaza, president of the American College of Preventive Medicine, discusses the future of opioid research priorities.
Dr Adam T. Perzynski joins Ethics Talk to discuss his article, coauthored with Dr Kurt C. Stange: “How Should Clinicians Ally With Patients Whose Health Is Unlikely to Be Improved by Even Numerous Clinical Encounters?”
Dr Brent M. Kious joins Ethics Talk to discuss his article, coauthored with Dr Ryan H. Nelson: “Does It Matter Whether a Psychiatric Intervention Is ‘Palliative’?”
Dr Cynthia Geppert joins Ethics Talk to discuss how teaching health professions students and trainees about palliative psychiatry reinvigorates core philosophy of medicine investigations into what health care is for.
Clinicians have an ethical obligation to provide high-quality care to incarcerated and justice-involved patients, which means being knowledgeable and empathic about the challenges these patients face. This month, we explore patient, student, and clinician perspectives on correctional health care.
This month, AMA Journal of Ethics theme editor Sarah Waliany, a fourth-year medical student at Stanford University School of Medicine, interviewed Louise Andrew, MD, JD, about mental health challenges for physicians and medical students and some strategies for colleagues to assist and intervene.
In the interview, Dr. Klasko discusses why team-based care is a key component in the future of health care and why medical students and residents should be taught in medical school how to practice as team members with their medical colleagues and staff.
Dr Katherin M. Duthie joins Ethics Talk to discuss her article, coauthored with Dr Kathryn A. Dong: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?”
Dr Kelly Gillespie joins Ethics Talk to discuss her article, coauthored with Dr Taleed El-Sabawi: “When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond?”